Canadian study examines QT-interval prolonging drug interactions with fluoroquinolones in older women with uncomplicated urinary tract infections in long-term care.
Study compares urinary albumin-to-creatinine ratio with finerenone–empagliflozin versus the single agents alone in patients with chronic kidney disease and type 2 diabetes.